Affymax Inc Com (NASDAQOTH:AFFY)

CAPS Rating: 1 out of 5

The Company is a biopharmaceutical company developing novel peptide-based drug candidates to improve the treatment of serious and often life-threatening conditions.


Player Avatar acts20 (23.29) Submitted: 12/7/2011 5:31:28 PM : Outperform Start Price: $7.40 AFFY Score: -108.30

Wish I would't have sold 30% of my shares. Hope to see $12 in a month

Member Avatar PinkFloydRoadie (< 20) Submitted: 2/25/2013 2:20:25 PM
Recs: 0

Uh, now I am guessing you wish you had sold all of it !
I had this stock for awhle about a year ago and only made about 5% on it and decided it was not worth the risk of failure with their only product. I think people need to consider these consequences. At this new price, I might be willing to risk a few bucks on a comeback if it levels out in price after a week, but realizing it could go bankrupt. In my estimatation, this stock is not even worth $1.80 without the drug.

Featured Broker Partners